SPA-10091-HCl
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
SPA-10091-HCl is a DOT1L degrader that selectively degrades the DOT1L protein via the nuclear ubiquitin-proteasome pathway, thereby inhibiting H3K79 methylation in CRPC cells. It also inhibits DOT1L enzymatic activity (IC50 = 0.87 ?M), induces apoptosis, and significantly suppresses tumor growth in vivo.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
FAB92292JF525 0.1 mL
Mouse Monoclonal VSIG3/IGSF11 Antibody (973408) [Janelia Fluor 525]
Ask
View Details 